Brister Mark 4
4 · OBALON THERAPEUTICS INC · Filed Jan 28, 2020
Insider Transaction Report
Form 4
Brister Mark
VP of Research and Development
Transactions
- Award
Restricted Stock Units
2020-01-24+110,281→ 110,281 total→ Common Stock (110,281 underlying)
Footnotes (1)
- [F1]Each restricted stock unit represents a right to receive one share of the Issuer's common stock, the cash equivalent thereof, or a combination of both, based on the achievement of stock price goals over a three-year performance period ending December 31, 2022.